Astellas Pharma GmbH
Industry / private company
Location:
München,
Germany (DE)
ISNI: 0000000405547363
ROR: https://ror.org/04bdk6464
Show on Map:
Renal Function and Patient-Reported Outcomes in Stable Kidney Transplant Patients Following Conversion From Twice-Daily Immediate-Release Tacrolimus to Once-Daily Prolonged-Release Tacrolimus: A 12-Month Observational Study in Routine Clinical Practice in Germany (ADAGIO) (2021)
Hugo C, Weihprecht H, Banas B, Schröppel B, Jank S, Arns W, Schenker P, et al.
Journal article
A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects (2018)
Schaffler K, Yassen A, Reeh P, Passier P
Journal article